Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition (PANDA)
A Multicenter Prospective Observational Study to Analyze Various ICP Derived Parameters and Clinical Status in Neurosurgical Critical Patients Through Big Data Acquisition
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Guoyi Gao, Dr.
- Phone Number: +86-021-68383709
- Email: guoyigao@gmail.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200127
- Recruiting
- Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University
-
Contact:
- Guoyi Gao, M.D.
- Phone Number: +86-021-68383709
- Email: guoyigao@gmail.com
-
Principal Investigator:
- Guoyi Gao, M.D.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18-65 years old
- Intracranial lesion underwent ICP sensor implantation
- Informed consent obtained
Exclusion Criteria:
- No consent
- A life-threatening injury to an organ other than the brain
- Known pregnancy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Glasgow Outcome Scale(GOS)
Time Frame: within 3 months after enrollment
|
within 3 months after enrollment
|
|
Glasgow Coma Scale(GCS)
Time Frame: within 3 months after enrollment
|
within 3 months after enrollment
|
|
Disability Rating Scale (DRS)
Time Frame: within 3 months after enrollment
|
within 3 months after enrollment
|
|
Mean intracranial pressure(ICP) value
Time Frame: throughout ICP monitoring, average 7 days
|
throughout ICP monitoring, average 7 days
|
|
Correlation between pulse amplitude and mean intracranial pressure(RAP)
Time Frame: throughout ICP monitoring, average 7 days
|
throughout ICP monitoring, average 7 days
|
|
Pressure-reactivity index(PRx)
Time Frame: throughout ICP monitoring, average 7 days
|
throughout ICP monitoring, average 7 days
|
|
Pulse amplitude of ICP(AMP)
Time Frame: throughout ICP monitoring, average 7 days
|
throughout ICP monitoring, average 7 days
|
|
ICP-arterial blood pressure(ABP) wave amplitude correlation(IAAC)
Time Frame: throughout ICP monitoring, average 7 days
|
throughout ICP monitoring, average 7 days
|
|
Cerebral perfusion pressure(CPP)
Time Frame: throughout ICP monitoring, average 7 days
|
throughout ICP monitoring, average 7 days
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):813-21. doi: 10.1136/jnnp.2003.033126.
- Di Ieva A, Schmitz EM, Cusimano MD. Analysis of intracranial pressure: past, present, and future. Neuroscientist. 2013 Dec;19(6):592-603. doi: 10.1177/1073858412474845. Epub 2013 Feb 6.
- Eide PK, Sorteberg A, Bentsen G, Marthinsen PB, Stubhaug A, Sorteberg W. Pressure-derived versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in relation to early clinical state and 12-month outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2012 May;116(5):961-71. doi: 10.3171/2012.1.JNS111313. Epub 2012 Feb 10.
- Czosnyka M, Smielewski P, Timofeev I, Lavinio A, Guazzo E, Hutchinson P, Pickard JD. Intracranial pressure: more than a number. Neurosurg Focus. 2007 May 15;22(5):E10. doi: 10.3171/foc.2007.22.5.11.
- Hamilton R, Xu P, Asgari S, Kasprowicz M, Vespa P, Bergsneider M, Hu X. Forecasting intracranial pressure elevation using pulse waveform morphology. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:4331-4. doi: 10.1109/IEMBS.2009.5332749.
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Renjineuro-BDA(2017)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.